Veracyte reported $1.17B in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 441.3M 24.65M
Agilent A:US $ 10455M 128M
Anika Therapeutics ANIK:US $ 342.24M 5.3M
Arrowhead Research ARWR:US $ 703.58M 65.04M
Biocept BIOC:US $ 61.94M 1.53M
Bruker BRKR:US $ 3550.7M 99.3M
Exact Sciences EXAS:US $ 6490.54M 194.35M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Illumina ILMN:US $ 15274M 57M
Immunogen IMGN:US $ 481.71M 44.06M
Intrexon XON:US $ 335.57M 24.29M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Laboratory Of America LH:US $ 20728.4M 343M
Ligand Pharmaceuticals LGND:US $ 1105.18M 192.41M
Myriad Genetics MYGN:US $ 1255.4M 65.3M
Rigel Pharmaceuticals RIGL:US $ 149.07M 18.25M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Siemens SIE:GR € 143946M 463M
Sonic Healthcare SHL:AU $ 12.46B 703.2M
Thermo Fisher Scientific TMO:US $ 92747M 2376M
Veracyte VCYT:US $ 1173.59M 14.24M
Waters WAT:US $ 3041.27M 53.66M